...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: 2023 Outlook per MD&A

Investalot

I got in this right before the assure trial failure in 2013 at about $3 and then built a nice position for the BOM trial failure. Will this ever see $20 again? By the looks of the MD&A they are still beating the drums. Covid and BOM2 trials planned to kick off in 2023 and double the trial participants - all with non-dilutive financing. Who knows? Looks like another 2 or 3 years before RVX sees an interim result. Possibly late 2024 results for a Covid trial.

Chicagoest

Share
New Message
Please login to post a reply